TGFB1 and hepatocellular carcinoma: The perspective of conceiving more effective immuno-targeting therapies in HCC treatment might benefit from a stratification of patients based on both the presence and functional status on intra-tumor immune cells subsets and the expression of micro-environmental factors such as TGFβ that impact on the activity of these cells.